These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15636441)

  • 1. Factor V leiden is a risk factor for myocardial infarction in young Turkish men.
    Hobikoglu GF; Akyuz U; Akyuz F; Ozer O; Güney D; Narin A; Unaltuna N
    Acta Cardiol; 2004 Dec; 59(6):594-7. PubMed ID: 15636441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
    Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
    Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.
    Rosendaal FR; Siscovick DS; Schwartz SM; Beverly RK; Psaty BM; Longstreth WT; Raghunathan TE; Koepsell TD; Reitsma PH
    Blood; 1997 Apr; 89(8):2817-21. PubMed ID: 9108400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of factor V Leiden in patients with acute myocardial infarction.
    Gowda MS; Zucker ML; Vacek JL; Carriger WL; Van Laeys DL; Rachel JM; Strope BD
    J Thromb Thrombolysis; 2000 Jan; 9(1):43-5. PubMed ID: 10590188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M; Celik S; Uçar F; Kaplan S; Ovali E; Erdöl C
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction.
    Celik S; Ovali E; Baykan M; Uçar F; Erdöl C; Durmuş I; Kaplan S
    Acta Cardiol; 2001 Feb; 56(1):1-6. PubMed ID: 11315119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age as a risk factor for myocardial infarction in Leiden mutation carriers.
    Baranovskaya S; Kudinov S; Fomicheva E; Vasina V; Solovieva D; Khavinson V; Schwartz E
    Mol Genet Metab; 1998 Jun; 64(2):155-7. PubMed ID: 9705241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.
    Redondo M; Watzke HH; Stucki B; Sulzer I; Biasiutti FD; Binder BR; Furlan M; Lämmle B; Wuillemin WA
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1020-5. PubMed ID: 10195931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor V Leiden and myocardial infarction: a case, review of the literature with a meta-analysis].
    Doix S; Mahrousseh M; Jolak M; Laurent Y; Lorenzini JL; Binquet C; Zeller M; Cottin Y; Wolf JE
    Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):143-9. PubMed ID: 12938565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of factor V Leiden mutation in Egyptian cases with myocardial infarction.
    Settin A; Dowaidar M; El-Baz R; Abd-Al-Samad A; El-Sayed I; Nasr M
    Hematology; 2008 Jun; 13(3):170-4. PubMed ID: 18702875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction.
    Tanis BC; Bloemenkamp DG; van den Bosch MA; Kemmeren JM; Algra A; van de Graaf Y; Rosendaal FR
    Br J Haematol; 2003 Aug; 122(3):471-8. PubMed ID: 12877676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries.
    Dacosta A; Tardy-Poncet B; Isaaz K; Cerisier A; Mismetti P; Simitsidis S; Reynaud J; Tardy B; Piot M; Decousus H; Guyotat D
    Heart; 1998 Oct; 80(4):338-40. PubMed ID: 9875108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic intracranial hypertension and factor V Leiden mutation].
    Younes S; Aissi M; Chérif Y; Daoussi N; Boughammoura A; Frih Ayed M; Sfar MH; Jerbi S
    J Mal Vasc; 2014 Jul; 39(4):270-3. PubMed ID: 24908418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of myocardial infarction related to factor V Leiden mutation: a meta-analysis.
    Dowaidar M; Settin A
    Genet Test Mol Biomarkers; 2010 Aug; 14(4):493-8. PubMed ID: 20642359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
    Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
    Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels.
    Arsov T; Miladinova D; Spiroski M
    Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.